This article explores how orbital biomanufacturing enhances resilience and operations in space, suggesting important implications for multiple sectors.
Space-based biomanufacturing has historically focused on long-duration crewed and exploration missions, but its greater potential lies in supporting in-space logistics, manufacturing, and servicing in Earth orbit. This article provides a strategic perspective on how shifting investments, policy, and R&D to orbital biomanufacturing could revolutionize defense, commercial, and civil sectors by enhancing supply chain resiliency, operational flexibility, ethical debris management, and commercial viability in Earth orbit.
No takes yet. Share an insight, caveat, or question.
Andrew KD Younger (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: